Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology

Sam Thissen1, Iris G Vos, Tobien H Schreuder

  • 1Department of Neurology, Atrium Medical Centre, Heerlen, The Netherlands.

Headache
|May 28, 2014
PubMed
Abstract

Insights

Persistent migraine aura without infarction (PMA) is rare, with prolonged aura symptoms. Lamotrigine shows potential efficacy, but functional imaging and treatment data remain inconsistent, requiring further research into PMA pathophysiology.

Area of Science:

  • Neurology
  • Neuroscience
  • Headache Medicine

Background:

  • Persistent migraine aura without infarction (PMA) is a rare neurological condition characterized by aura symptoms lasting over a week without evidence of infarction.
  • Two subtypes exist: persistent primary visual disturbance (PPVD) and typical aura (TA).

Purpose of the Study:

  • To review existing literature and present four new cases of PMA.
  • To identify potential associations and clarify functional investigation findings in PMA.

Main Methods:

  • Systematic literature search from 1991 to March 2014.
  • Inclusion of all reported PMA cases meeting International Classification of Headache Disorders criteria.
  • Analysis of four newly described PMA cases.

Main Results:

  • 47 PMA cases identified (27 PMA-PPVD, 19 PMA-TA).
  • Mean age of onset 30 years; symptom duration varied widely (9 days to 28 years).
  • Inconsistent findings in functional imaging (SPECT/PET); lamotrigine suggested as most effective treatment, though overall treatment effects are limited.

Conclusions:

  • Despite 47 reviewed cases, significant questions about PMA persist.
  • Inconsistent functional study results and treatment effects highlight knowledge gaps.
  • The underlying pathophysiology of persistent migraine aura without infarction remains largely unknown.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins...
19
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
14
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
4.5K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
587